MULTICOMPONENT MEDICINAL PREPARATIONS: ADVANTAGES OF THEIR USE IN CLINICAL PRACTICE


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The prospects of the use of multicomponent preparations in clinical practice are discussed on the base of the analysis of formularies. Today, many diseases are caused by stress, improper lifestyles associated with hypodynamie, impaired nutrition, and environmental distress. In this situation, it is necessary to regulate pharmacotherapy with complex drugs at the systemic level, which provides correction along the hierarchical ladder of life process management, mobilization of internal reserves for maintaining health, interfacing the action of the ingredients of the complex with the functional systems of the patient. In folk medicine of many countries, traditional eastern medicine, for thousands of years, multi-component (complex, combined, complex) drugs have been used, containing several ingredients, two or more active pharmacological substances. The inclusion of a number of medicinal components in one ready-made dosage form creates great amenities for the patient, eliminating the need to take many separate drugs, observing the order of their use, and experiencing inconvenience in the treatment and prevention of the disease. From the point of view of evidence-based medicine, they have withstood millennial trials, they have laid down centuries of experience in their successful use, and today, it is, multicomponent drugs of traditional medicine that are most interesting for research. The expressed effectiveness of the combined preparation is due to potentiation of the action of ingredients with unidirectional activity, but with different mechanisms. By reducing the proportion of components in the complex, the risk of undesirable effects when taken is reduced. Small doses of the components of the complex preparation allow modulating the natural processes of health restoration, accompanying the action of the main substances and creating conditions for the manifestation of the activity of the accompanying elements of the complex. The studies have shown that the complex drugs have a number of advantages: ease of use; drug potentiation; risk reduction of side effects; costs reduction; system effect of the complex as pharmacotherapeutic system. The emphasis is laid on the traditional combined remedies as their efficacy and safety have been proved for thousands of years and they are of great interest at present time.

Full Text

Restricted Access

About the authors

S. M Nikolaev

Institute of General and Experimental Biology SB RAS; Buryat State University named after Dorzhi Banzarov

Email: smnikolaev@mail.ru
Dr.Sc. (Med.), Professor, Chief Research Scientist of the Laboratory of Experimental Pharmacology, Institute of General and Experimental Biology SB RAS; Professor of the Department of Pharmacology and Traditional Medicine, Medical institute, Buryat State University named after Dorzhi Banzarov Ulan-Ude

L. N Shantanova

Institute of General and Experimental Biology SB RAS; Buryat State University named after Dorzhi Banzarov

Email: shantanova@mail.ru
Dr.Sc. (Biol.), Professor, Head of the Laboratory of Biologically Active Substances Safety, Institute of General and Experimental Biology SB RAS; Professor of the Department of Human Anatomy and Physiology, Medical Institute, Buryat State University named after Dorzhi Banzarov Ulan-Ude

V. B Khobrakova

Institute of General and Experimental Biology SB RAS; Buryat State University named after Dorzhi Banzarov

Email: val0808@mail.ru
Dr.Sc. (Biol.), Associate Professor, Head of the Laboratory of Experimental Pharmacology, Institute of General and Experimental Biology SB RAS; Professor of the Department of Human General Pathology, Medical Institute, Buryat State University named after Dorzhi Banzarov Ulan-Ude

Ya. G Razuvaeva

Institute of General and Experimental Biology SB RAS; Buryat State University named after Dorzhi Banzarov

Email: tatur75@mail.ru
Dr.Sc. (Biol.), Leading Research Scientist of Laboratory of Biologically Active Substances Safety, Institute of General and Experimental Biology SB RAS; Senior Lecturer of the Department of Human Anatomy and Physiology, Medical Institute, Buryat State University named after Dorzhi Banzarov Ulan-Ude

S. A Chukaev

Buryat State University named after Dorzhi Banzarov

Email: s_chukaev@mail.ru
Ph.D. (Med.), Associate Professor, Senior Lecturer of the Department of Pharmacology and Traditional Medicine, Medical Institute Ulan-Ude

V. E Khitrikheev

Buryat State University named after Dorzhi Banzarov

Email: khitrikheev-ve@yandex.ru
Dr.Sc. (Med.), Professor, Head of the Department of Hospital Surgery, Medical Institute Ulan-Ude

References

  1. Николаев С.М. Фитофармакотерапия и фитофармакопрофилактика заболеваний. Улан-Удэ, 2012; 286 с.
  2. Дагвацэрэн Б. Цогзальтоголдор «Дорвонундэс» - ийн «Номлохынундэс» Тайлбар, Тайлал. Улаанбаатар, 2015; 209 с.
  3. Geng I., Huang W., Ren T., MaX. Practical Traditional Chinese and Pharmacology: Herbal Formulas. Beijing: New World Press. 1991; 259 p.
  4. Киселева Т.Л. Кинетический синергизм в фитотерапии: традиционные препараты с точки зрения современных научных представлений. Традиционная медицина. 2011; 2: 50-57.
  5. Лубсандоржиева П.Б. Разработка и стандартизация фитосредств для лечения и профилактики заболеваний органов пищеварения. Улан-Удэ, 2016; 280 с.
  6. Ферубко Е.В., Рендюк Т.Д., Пупыкина К.А., Даргаева Т.Д., Николаев С.М. Лекарственные препараты растительного происхождения для профилактикии лечения заболеваний органов пищеварения. М., 2020; 210 с.
  7. Лубсандоржиева П.Б., Ферубко Е.В., Даргаева Т.Д. Методологический подход к созданию много-компонентных лекарственных растительных средств для лечения заболеваний органов пищеварения. Традиционная медицина. 2018; 3:35-39.
  8. Баторова С.М., Базарон Э.Г. Рецептура препаратов традиционной монгольской медицины. Улан-Удэ, 2015; 272 с.
  9. Goldman P. Herbal medicines today and the roots of modern pharmacology. Ann. International Med. 2001; 135(8): 594-600.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies